World Anti-Doping Agency Report issue

Foundation Phase 1 Phase 4

Organization Overview

First Clinical Trial
2013
NCT01903785
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

World Anti-Doping Agency (WADA)

Active Ingredients

Drugs in Phase 4 Trials (1)

albuterol (proventil) (1 trial)

Drugs in Phase 1 Trials (2)

ethanol (1 trial)

tea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcohol Drinking (Phase 1)

Respiratory Aspiration (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3